Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-123093
Filing Date
2016-05-24
Accepted
2016-05-24 21:35:19
Documents
1
Period of Report
2016-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5944
  Complete submission text file 0001209191-16-123093.txt   7309
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address
Castagna Michael (Reporting) CIK: 0001674282 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50865 | Film No.: 161673316